Stockreport

Immix Biopharma to Present at the 37th Annual Piper Sandler Healthcare Conference

Immix Biopharma, Inc.  (IMMX) 
PDF Los Angeles, CA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company de [Read more]